Advanced extragonadal yolk sac tumor serially followed up with (18)F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein

J Obstet Gynaecol Res. 2012 Mar;38(3):605-9. doi: 10.1111/j.1447-0756.2011.01752.x. Epub 2012 Feb 22.

Abstract

Although yolk sac tumors (YSTs) are the second most common malignant germ cell tumor of the ovary, those arising from the omentum or pelvic peritoneum are extremely rare and have no established treatment guidelines. We report a case of a primary YST disseminated throughout the abdomen and associated with a high serum alpha-fetoprotein (AFP) elevation (441 611 ng/ml). Optimal cytoreduction was not achieved in order to preserve the patient's fertility and avoid adjacent organ injury. Residual tumor responded to adjuvant chemotherapy with a sharp decline in AFP levels, and confirmed remission was documented by serial (18)F-fluorodexyglucose-positoron emission tomography and computerized tomography (FDG-PET/CT). In cases of advanced YST with unresectable residual disease, AFP levels combined with FDG-PET/CT scans may be a helpful way to monitor treatment response and assist in treatment planning for a disease that primarily affects young women who may desire to preserve fertility.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Neoplasms / blood
  • Abdominal Neoplasms / diagnostic imaging*
  • Adult
  • Endodermal Sinus Tumor / blood
  • Endodermal Sinus Tumor / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Multimodal Imaging*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Tomography, X-Ray Computed*
  • alpha-Fetoproteins / metabolism*

Substances

  • AFP protein, human
  • Radiopharmaceuticals
  • alpha-Fetoproteins
  • Fluorodeoxyglucose F18